(Q37791462)

23 August 2017

Comparison of half-dose and full-dose gadolinium MR contrast on the enhancement of bone and soft tissue tumors (English)

1 reference

23 August 2017

Colleen M Costelloe

1

1 reference

23 August 2017

William A Murphy

2

1 reference

23 August 2017

Tamara M Haygood

3

1 reference

23 August 2017

Rajendra Kumar

4

1 reference

23 August 2017

Kevin W McEnery

5

1 reference

23 August 2017

R Jason Stafford

6

1 reference

23 August 2017

Anjali Roy

7

1 reference

23 August 2017

Roland L Bassett

8

1 reference

23 August 2017

Robyn K Harrell

9

1 reference

23 August 2017

John E Madewell

10

1 reference

23 August 2017

24 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

40

1 reference

23 August 2017

3

1 reference

23 August 2017

327-333

1 reference

https://scigraph.springernature.com/pub.10.1007/s00256-010-1028-8

23 August 2017

0 references

cites work

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Large sample of nephrogenic systemic fibrosis cases from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

ACR Guidance Document for Safe MR Practices: 2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Gadolinium-enhanced MRI of soft tissue masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Incidence of nephrogenic systemic fibrosis at two large medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Nephrogenic systemic fibrosis: center case review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-010-1028-8

Musculoskeletal neoplasms: static and dynamic Gd-DTPA--enhanced MR imaging

21 January 2018

1 reference

12 December 2020

MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations

1 reference

12 December 2020

Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy

1 reference

12 December 2020

Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy

1 reference

12 December 2020

Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin

1 reference

12 December 2020

Static, dynamic and first-pass MR imaging of musculoskeletal lesions using gadodiamide injection.

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy with systemic involvement

1 reference

12 December 2020

Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength

1 reference

12 December 2020

Staging and re-staging of soft tissue sarcoma using MRI. Usefulness of contrast media

1 reference

12 December 2020

10.1007/S00256-010-1028-8

Identifiers

DOI

1 reference

23 August 2017

1 reference